Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Entamoeba histolytica | steroid 5-alpha reductase, putative | 0.0311 | 1 | 1 |
Schistosoma mansoni | alpha-galactosidase/alpha-n-acetylgalactosaminidase | 0.0103 | 0.2951 | 0.4622 |
Schistosoma mansoni | alpha-galactosidase/alpha-n-acetylgalactosaminidase | 0.0103 | 0.2951 | 0.4622 |
Toxoplasma gondii | 3-oxo-5-alpha-steroid 4-dehydrogenase | 0.0311 | 1 | 1 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0046 | 0.1022 | 0.1601 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0034 | 0.062 | 0.062 |
Plasmodium vivax | 3-oxo-5-alpha-steroid 4-dehydrogenase, putative | 0.0044 | 0.0947 | 0.5 |
Schistosoma mansoni | alpha-galactosidase/alpha-n-acetylgalactosaminidase | 0.0069 | 0.179 | 0.2803 |
Mycobacterium tuberculosis | Probable oxidoreductase | 0.0275 | 0.8791 | 0.5 |
Brugia malayi | Melibiase family protein | 0.0069 | 0.179 | 0.179 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.005 | 0.1154 | 0.1154 |
Echinococcus granulosus | 3 oxo 5 alpha steroid 4 dehydrogenase C terminal | 0.0044 | 0.0947 | 0.1484 |
Echinococcus multilocularis | muscleblind protein 1 | 0.015 | 0.4549 | 0.7124 |
Trypanosoma cruzi | 3-oxo-5-alpha-steroid 4-dehydrogenase, putative | 0.0311 | 1 | 1 |
Echinococcus multilocularis | Alpha N acetylgalactosaminidase | 0.0103 | 0.2951 | 0.4622 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0046 | 0.1022 | 0.1601 |
Echinococcus granulosus | hormone sensitive lipase | 0.0204 | 0.6385 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.015 | 0.4549 | 0.4549 |
Schistosoma mansoni | synaptic glycoprotein sc2 related | 0.0044 | 0.0947 | 0.1484 |
Loa Loa (eye worm) | hypothetical protein | 0.015 | 0.4549 | 0.4549 |
Echinococcus granulosus | Alpha N acetylgalactosaminidase | 0.0103 | 0.2951 | 0.4622 |
Loa Loa (eye worm) | hypothetical protein | 0.0044 | 0.0947 | 0.0947 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0046 | 0.1022 | 0.1022 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.005 | 0.1154 | 0.1154 |
Trichomonas vaginalis | 3-oxo-5-alpha-steroid 4-dehydrogenase, putative | 0.0311 | 1 | 1 |
Echinococcus multilocularis | synaptic glycoprotein sc2 | 0.0044 | 0.0947 | 0.1484 |
Loa Loa (eye worm) | hypothetical protein | 0.0204 | 0.6385 | 0.6385 |
Leishmania major | 3-oxo-5-alpha-steroid 4-dehydrogenase-like protein | 0.0311 | 1 | 0.5 |
Trypanosoma brucei | 3-oxo-5-alpha-steroid 4-dehydrogenase-like, putative | 0.0311 | 1 | 1 |
Echinococcus granulosus | muscleblind protein | 0.015 | 0.4549 | 0.7124 |
Trichomonas vaginalis | 3-oxo-5-alpha-steroid 4-dehydrogenase, putative | 0.0311 | 1 | 1 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0046 | 0.1022 | 0.1601 |
Mycobacterium ulcerans | hypothetical protein | 0.0311 | 1 | 1 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0046 | 0.1022 | 0.1022 |
Schistosoma mansoni | alpha-galactosidase/alpha-n-acetylgalactosaminidase | 0.0103 | 0.2951 | 0.4622 |
Echinococcus multilocularis | muscleblind protein | 0.015 | 0.4549 | 0.7124 |
Loa Loa (eye worm) | hypothetical protein | 0.0311 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0069 | 0.179 | 0.179 |
Loa Loa (eye worm) | hypothetical protein | 0.0044 | 0.0947 | 0.0947 |
Trypanosoma cruzi | 3-oxo-5-alpha-steroid 4-dehydrogenase, putative | 0.0311 | 1 | 1 |
Brugia malayi | Synaptic glycoprotein SC2 | 0.0044 | 0.0947 | 0.0947 |
Schistosoma mansoni | hormone-sensitive lipase (S09 family) | 0.0204 | 0.6385 | 1 |
Onchocerca volvulus | 0.0044 | 0.0947 | 0.5 | |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.005 | 0.1154 | 0.1154 |
Echinococcus granulosus | synaptic glycoprotein sc2 | 0.0044 | 0.0947 | 0.1484 |
Schistosoma mansoni | synaptic glycoprotein sc2 related | 0.0044 | 0.0947 | 0.1484 |
Loa Loa (eye worm) | hypothetical protein | 0.0034 | 0.062 | 0.062 |
Schistosoma mansoni | alpha-galactosidase/alpha-n-acetylgalactosaminidase | 0.0069 | 0.179 | 0.2803 |
Trichomonas vaginalis | alpha-galactosidase/alpha-N-acetylgalactosaminidase, putative | 0.0069 | 0.179 | 0.0931 |
Toxoplasma gondii | melibiase subfamily protein | 0.0103 | 0.2951 | 0.2214 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0046 | 0.1022 | 0.1601 |
Plasmodium falciparum | polyprenol reductase, putative | 0.0044 | 0.0947 | 0.5 |
Schistosoma mansoni | hormone-sensitive lipase (S09 family) | 0.0204 | 0.6385 | 1 |
Giardia lamblia | Synaptic glycoprotein SC2 | 0.0044 | 0.0947 | 0.5 |
Echinococcus multilocularis | 3 oxo 5 alpha steroid 4 dehydrogenase, C terminal | 0.0044 | 0.0947 | 0.1484 |
Plasmodium vivax | polyprenol reductase, putative | 0.0044 | 0.0947 | 0.5 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0046 | 0.1022 | 0.1601 |
Schistosoma mansoni | alpha-galactosidase/alpha-n-acetylgalactosaminidase | 0.0103 | 0.2951 | 0.4622 |
Echinococcus multilocularis | Glycoside hydrolase, family 27 | 0.0103 | 0.2951 | 0.4622 |
Schistosoma mansoni | hypothetical protein | 0.0034 | 0.062 | 0.0971 |
Schistosoma mansoni | hormone-sensitive lipase (S09 family) | 0.0204 | 0.6385 | 1 |
Trichomonas vaginalis | 3-oxo-5-alpha-steroid 4-dehydrogenase, putative | 0.0311 | 1 | 1 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0046 | 0.1022 | 0.1601 |
Brugia malayi | Muscleblind-like protein | 0.015 | 0.4549 | 0.4549 |
Echinococcus multilocularis | hormone sensitive lipase | 0.0204 | 0.6385 | 1 |
Plasmodium falciparum | 3-oxo-5-alpha-steroid 4-dehydrogenase, putative | 0.0044 | 0.0947 | 0.5 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0046 | 0.1022 | 0.1601 |
Loa Loa (eye worm) | hypothetical protein | 0.005 | 0.1154 | 0.1154 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.